Drug Trial Radar · NCT05585983
INfluenza VaccInation To Mitigate typE 1 Diabetes
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Dec 14, 2022
Primary completion
May 1, 2027
Study completion May 1, 2028
Sponsor
- Lead sponsor
- Aarhus University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 7 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.
Conditions
- Diabetes Mellitus, Type 1
Interventions
Vaxigrip Tetra Sanofi Pasteur EuropeBiological
We will use 0.5 mL standard dose quadrivalent influenza vaccine containing 15 μg of hemagglutinin per strain consistent with WHO recommendations according to season.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in fasting residual β cell (C-peptide) function.Time frame: 12 months
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Aalborg University Hospital
Aalborg, Denmark · Recruiting
Aarhus University Hospital
Aarhus, Denmark · Recruiting
Steno Diabetes Center Copenhagen
Copenhagen, Denmark · Recruiting
Gødstrup Hospital
Herning, Denmark · Recruiting
Holbaek Sygehus
Holbæk, Denmark · Recruiting
Nykoebing F Sygehus
Nykøbing Falster, Denmark · Recruiting
Randers Regional Hospital
Randers, Denmark · Recruiting
Sjællands Universitetssygehus
Roskilde, Denmark · Recruiting
Slagelse Hospital
Slagelse, Denmark · Recruiting
Viborg Regional Hospital
Viborg, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.